Shares of Cohance Lifesciences surged 20% on Monday after the appointment of former Cipla CEO Umang Vohra as its new Executive Chairman and Group CEO. His leadership is expected to drive transformation, scale operations, and strengthen global partnerships as the company enters its next growth phase.
Recent Posts
- A long-time developer wants to split Bitcoin blockchain and reassign Satoshi coins. The community is calling it a theft
- Pudgy Penguins, BAYC rally masks a shrinking NFT market as volumes and users fall
- Iran reportedly proposes Hormuz Strait deal to U.S. Here’s where things stand — and what’s next for markets
- Acko lines up ICICI Sec, Kotak, Morgan Stanley for $2 billion IPO
- Varun Beverages Q4 results: Net profit jumps 20% at ₹872.3 crore YoY, revenue up 18.3%; ₹0.50 dividend declared